- This event has passed.
ALS Town Hall: Discussion on Tegoprubart Phase 2a Results
July 27, 2022 @ 3:00 pm - 4:00 pm EDT
Free
ALS Town Hall: Discussion on Tegoprubart Phase 2a Results
Led by Dr. David-Alexandre C. Gros and Dr. Steve Perrin of Eledon Pharmaceuticals
Wednesday, July 27, 2022 | 3:00 – 4:00pm EDT
On Wednesday, July 27, 2022, ALS TDI will be hosting a new ALS Town Hall discussion on tegoprubart. Tegoprubart is a potential treatment for ALS that was invented at ALS TDI and recently completed a phase 2a trial carried out by Eledon Pharmaceuticals. The discussion will be led by Eledon’s Chief Executive Officer, Dr. David-Alexandre C. Gros, and President and Chief Scientific Officer, Dr. Steve Perrin, who will provide an overview of the drug mechanisms and the trial results.
